Multiple Assemblies exist for SMTL entry 8sce
Crystal structure of IRAK4-HSA complexed with N-[(2R)-2-FLUORO-3-HYDROXY-3-METHYLBUTYL]-6-[(5-FLUOROPYRI-YL)AMINO]-4-[(PROPAN-2-YL)AMINO]PYRIDINE-3-CARBOXAMIDE; X-RAY DIFFRACTION 1.89 Å

	SMTL ID 8sce.1 Ligands N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 8sce.2 Ligands N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 8sce.3 Ligands SULFATE ION; N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 8sce.4 Ligands SULFATE ION; N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer